Fig. 5From: Real-world daptomycin use across wide geographical regions: results from a pooled analysis of CORE and EU-COREClinical outcomes by primary pathogen. CoNS coagulase-negative staphylococci, MRSA methicillin-resistant S. aureus, MSSA methicillin-susceptible S. aureus, VRE vancomycin-resistant enterococciBack to article page